Compound Summary
Labetalol hydrochloride
Compound Information
Labetalol hydrochloride
Compound Name: | Labetalol hydrochloride |
Compound CID: | 71412 |
Synonyms: | Labetalol hydrochloride 32780-64-6 Labetalol HCL Amipress Presdate More... |
Iupac Name: | 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide;hydrochloride |
InChI: | InChI=1S/C19H24N2O3.ClH/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24;/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24);1H |
InChIKey: | WQVZLXWQESQGIF-UHFFFAOYSA-N |
Canonical Smiles: | CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O.Cl |
Isomeric Smiles: | CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O.Cl |
Molecular Weight: | 364.9 |
Molecular Formula: | C19H25ClN2O3 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Labetalol hydrochloride
Molecular Weight: | 364.9 |
Molecular Formula: | C19H25ClN2O3 |
Hydrogen Bond Donor Count: | 5 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 8 |
Heavy Atom Count: | 25 |
Complexity: | 385 |
Synonyms
Labetalol hydrochloride
| Labetalol hydrochloride | Labetalol hydrochloride |
|---|---|
Labetalol hydrochloride |
32780-64-6 |
Labetalol HCL |
Amipress |
Presdate |
Labetalol (hydrochloride) |
ScH 15719W |
AH 5158A |
2-Hydroxy-5-(1-hydroxy-2-((4-phenylbutan-2-yl)amino)ethyl)benzamide hydrochloride |
UNII-1GEV3BAW9J |
Sch-15719W |
Labetalol hydrochloride |
1GEV3BAW9J |
C19H25ClN2O3 |
32780-64-6 (HCl) |
MLS000069666 |
AH-5158A |
MFCD00057663 |
NSC-290312 |
AH-5158 hydrochloride;Sch-15719W |
Labetalol HCl (Mixture of Diastereomers) |
Labrocol |
Pressalolo |
SMR000058463 |
Ipolab |
2-Hydroxy-5-(1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl)benzamide HCl |
2-hydroxy-5-1-hydroxy-2-(4-phenylbutan-2-ylamino)ethylbenzamide hydrochloride |
2-hydroxy-5-1-hydroxy-2-(4-phenylbutan-2-ylamino)ethylbenzamide;hydrochloride |
5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide hydrochloride |
5-1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethylsalicylamide hydrochloride |
2-Hydroxy-5-1-hydroxy-2-(1-methyl-3-phenylpropyl)aminoethylbenzamide hydrochloride |
5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide monohydrochloride |
5-1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethylsalicylamide monohydrochloride |
DSSTox_CID_24654 |
DSSTox_RID_80378 |
DSSTox_GSID_44654 |
CCRIS 1086 |
SR-01000000209 |
EINECS 251-211-1 |
NSC 290312 |
2-hydroxy-5-(1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl)benzamide hydrochloride |
2-Hydroxy-5-(1-hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl)benzamide hydrochloride |
Normodyne (TN) |
Trandate (TN) |
Prestwick_290 |
EINECS 276-694-6 |
LabetalolHydrochloride |
Labetalol hydrochloride USAN:USP:JAN |
AH-5158 hydrochloride |
La.beta.lol hydrochloride |
Opera_ID_1625 |
Benzamide,monohydrochloride |
NCGC00016810-01 |
Salicylamide, hydrochloride |
CAS-32780-64-6 |
Salicylamide, 5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-, hydrochloride |
SCHEMBL41230 |
MLS001148626 |
MLS002222197 |
SPECTRUM1503243 |
CHEBI:6344 |
AH-5158A HYDROCHLORIDE |
CHEMBL1200323 |
DTXSID0044654 |
AMY8842 |
AOB5072 |
HMS1568H16 |
HMS1922M13 |
Pharmakon1600-01503243 |
SCH-15719W HYDROCHLORIDE |
72487-35-5 |
BCP13886 |
EX-A4940 |
HY-B1108 |
Tox21_110623 |
Tox21_302725 |
Tox21_500687 |
CCG-40314 |
Labetalol hydrochloride (JP17/USP) |
NSC290312 |
NSC758438 |
s4291 |
AKOS015895575 |
AC-1389 |
AH-5158 |
CS-4706 |
LP00687 |
NC00571 |
NSC-758438 |
SS-4219 |
VA11135 |
NCGC00094044-01 |
NCGC00094044-02 |
NCGC00094044-03 |
NCGC00094044-04 |
NCGC00094044-05 |
NCGC00256847-01 |
NCGC00261372-01 |
(R*,R*)-(1)-5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide monohydrochloride |
72487-34-4 |
Benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)-, monohydrochloride |
Benzamide,2-hydroxy-5-1-hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl-, hydrochloride(1:1) |
DB-048265 |
EU-0100687 |
FT-0630564 |
FT-0773231 |
SW196595-3 |
D00600 |
J10319 |
Labetalol hydrochloride, >98% (TLC), powder |
780L646 |
SR-01000000209-2 |
SR-01000000209-7 |
Q27252396 |
2-Hydroxy-5-(1-hydroxy-2-((4-phenylbutan-2-yl)amino)ethyl)benzamide HCl |
Labetalol hydrochloride, European Pharmacopoeia (EP) Reference Standard |
Labetalol hydrochloride, United States Pharmacopeia (USP) Reference Standard |
Labetalol Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material |
Benzamide, 2-hydroxy-5-1-hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl-, hydrochloride (1:1) |
BENZAMIDE,2-HYDROXY-5-(1S)-1-HYDROXY-2-(1R)-1-METHYL-3-PHENYLPROPYLAMINOETHYL-,HYDROCHLORIDE (1:1), REL- |
Experimental Data
Labetalol hydrochloride
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 11.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
Labetalol hydrochloride
Statistics Data
Labetalol hydrochloride
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 11.000000000000000 | 1 | 1 |
Statistics Data Visualization
Labetalol hydrochloride
